口服抗糖尿病药物对氨酸 - - ангиотензин - - 阿尔多斯特系统的影响
Xifeng Yang1,2, Yijie Qi1,2, Jinxuan Hao1,2
1Department of Endocrinology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Taiyuan, 030001, Shanxi, China.
European journal of clinical pharmacology
|April 1, 2025
概括
口服抗糖尿病药物对氨酸- ангиотензин- 阿尔多素系统 (RAAS) 的影响不同. 了解这些作用,比如SGLT2抑制剂降低雷宁,有助于管理糖尿病并发症和心血管健康.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 对于平衡至关重要,但过度活化会导致疾病.
- 高血糖症可以过度激活RAAS,导致糖尿病并发症.
- 口服抗糖尿病药对RAAS的影响需要全面总结.
研究的目的:
- 审查各种口服抗糖尿病药物对RAAS组件的影响.
主要方法:
- 对调查口服抗糖尿病药物和RAAS成分的研究的文献综述.
- 分析不同药物类调节RAAS活性的机制.
- 综合关于对素,血管新素II和阿尔多斯特的影响的研究结果.
主要成果:
- -葡萄糖携带载体抑制剂 (SGLT2i) 通过管球球体反来降低氨酸的产生.
- GLP-1受体激活剂 (GLP-1RA) 和DPP-4抑制剂 (DPP-4i) 直接或间接地抑制 ангиотензин II (Ang II).
- thiazolidinediones (TZDs) 和 Metformin 对 RAAS 组件表现出多种影响,包括雷宁,ACE 和阿尔多斯特.
结论:
- 口服抗糖尿病药物通过多种机制调节RAAS活性.
- 这些调制有助于抗高血压,抗炎,心脏保护和保护作用.
- 了解这些相互作用为糖尿病管理提供了显著的好处.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
456
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
456
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
406
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
406
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
548
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
548
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
128
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
128
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K